TrialBMC cancer2022

A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.

Zin W Myint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.